Pierre Socha

Pierre Socha is a prominent figure in the world of early-stage tech venture capital, particularly focusing on Healthtech, Human-Computer Interfaces, AI, Quantum, and Material Science investments as the Lead of Health & Bio investments at Amadeus Capital.

His educational background is illustrious, having studied executive programs at top institutions like Massachusetts Institute of Technology, Harvard Business School, and Stanford University Graduate School of Business. He holds an MSc in Environmental Economics from Aix-Marseille University and a BSc in Finance & Econometrics from the University of Strasbourg.

Pierre Socha's wealth of experience extends to various board memberships at organizations like Constructive Bio, V7, Quibim, Charco, Ori Biotech, and more. He also served as an investor in companies such as CS Genetics, AI VIVO, Biofidelity, Lightcast Discovery, and others. Additionally, he held positions ranging from Partner to Chief Strategy Officer at Amadeus Capital Partners and Avesthagen, where he also served as the CEO of the bioNutrition division, Managing Director - Europe, and in various other key roles.

Throughout his career, Pierre Socha has demonstrated a keen interest and expertise in driving strategic growth and innovation within the biotech and tech industries, making significant contributions to the companies he has been involved with.